Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...

The US Food and Drug Administration found no increased risk of suicidal behavior or ideation linked to popular weight-loss ...

Hormone therapy helps women. Now the FDA is reversing its warning on estrogen treatment which could change treatemtn for ...

The U.S. Food and Drug Administration will remove the "black box" warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms — a major turnaround that's likely to ...

Black box warnings can influence whether or not clinicians decide to prescribe a drug. SDI Productions/E+ via Getty Images A “black box” warning on a health product sounds pretty scary – maybe even ...

The FDA is weighing a change that could make warning labels on dietary supplements appear less often on packaging.

WASHINGTON D.C. —The U.S. Food and Drug Administration is mandating safety changes to opioid pain medication labels, a move officials say will better warn patients and prescribers about the risks of ...

WEST MICHIGAN — Menopause is the term to describe women no longer receiving natural estrogen from her ovaries, and for several years, women who would be excellent candidates for Menopause Hormone ...

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential ​risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli ...